Explore more publications!
Health Herald Grenada
Got News to Share?

Health Herald Grenada: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Herald Grenada.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on October 1, 2025

Immix Biopharma to Present at the 37th Annual Piper Sandler Healthcare Conference
October 1, 2025

Immix Biopharma to Present at the 37th Annual Piper Sandler Healthcare Conference

Indeterminate GlobeNewswire
Elutia Announces Closing of BioEnvelope Business Sale to Boston Scientific Corporation for $88 Million
October 1, 2025

Elutia Announces Closing of BioEnvelope Business Sale to Boston Scientific Corporation for $88 Million

Indeterminate GlobeNewswire
Profusa Adds a Leading French Critical Limb Ischemia Surgeon to Customer Base
October 1, 2025

Profusa Adds a Leading French Critical Limb Ischemia Surgeon to Customer Base

Indeterminate GlobeNewswire
TOMI Environmental Solutions Announces $175,000 Equipment Purchase by T.A.C.T., Signaling Continued Demand in Commercial Sector
October 1, 2025

TOMI Environmental Solutions Announces $175,000 Equipment Purchase by T.A.C.T., Signaling Continued Demand in Commercial Sector

Indeterminate GlobeNewswire
CMS New Technology Add-On Payment Expands Access to RECELL® for Patients with Non-Burn Acute Wounds
October 1, 2025

CMS New Technology Add-On Payment Expands Access to RECELL® for Patients with Non-Burn Acute Wounds

Indeterminate GlobeNewswire
Ernexa Therapeutics to Deliver Company Presentation at the Annual Cell & Gene Meeting on the Mesa
October 1, 2025

Ernexa Therapeutics to Deliver Company Presentation at the Annual Cell & Gene Meeting on the Mesa

Indeterminate GlobeNewswire
Maxion Therapeutics Appoints Joel Edwards as Chief Business Officer
October 1, 2025

Maxion Therapeutics Appoints Joel Edwards as Chief Business Officer

Indeterminate GlobeNewswire
Primary.Health Launches Nation's First Advanced Newborn Screening Case Management Platform
October 1, 2025

Primary.Health Launches Nation's First Advanced Newborn Screening Case Management Platform

Indeterminate GlobeNewswire
Myrtelle Announces Nature Medicine Publication of Interim Results from Its Phase 1/2 Clinical Trial of Investigational Gene Therapy rAAV-Olig001-ASPA for Canavan Disease
October 1, 2025

Myrtelle Announces Nature Medicine Publication of Interim Results from Its Phase 1/2 Clinical Trial of Investigational Gene Therapy rAAV-Olig001-ASPA for Canavan Disease

Indeterminate GlobeNewswire
Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $205 Million Series A Financing
October 1, 2025

Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $205 Million Series A Financing

Indeterminate GlobeNewswire
Catalyst Pharmaceuticals Announces $200 Million Share Repurchase Program
October 1, 2025

Catalyst Pharmaceuticals Announces $200 Million Share Repurchase Program

Indeterminate GlobeNewswire
Fortress Biotech and Cyprium Therapeutics Announce an Update on the NDA for CUTX-101
October 1, 2025

Fortress Biotech and Cyprium Therapeutics Announce an Update on the NDA for CUTX-101

Indeterminate GlobeNewswire
Stryker to announce financial results for its third quarter of fiscal year 2025
October 1, 2025

Stryker to announce financial results for its third quarter of fiscal year 2025

Indeterminate GlobeNewswire
Radiopharm Theranostics Receives Positive Recommendation from Data Safety and Monitoring Committee (DSMC) to Accelerate 177Lu-RAD202 Phase 1 ‘HEAT’ Dose Escalation Clinical Trial
October 1, 2025

Radiopharm Theranostics Receives Positive Recommendation from Data Safety and Monitoring Committee (DSMC) to Accelerate 177Lu-RAD202 Phase 1 ‘HEAT’ Dose Escalation Clinical Trial

Indeterminate GlobeNewswire
Diabetes Canada launches “Type Resilient,” a new brand campaign recognizing the resilience of people living with diabetes
October 1, 2025

Diabetes Canada launches “Type Resilient,” a new brand campaign recognizing the resilience of people living with diabetes

Indeterminate GlobeNewswire
Alignment Health Unveils 2026 Medicare Advantage Plans with Strong Benefits, Expanded Support for Seniors
October 1, 2025

Alignment Health Unveils 2026 Medicare Advantage Plans with Strong Benefits, Expanded Support for Seniors

Indeterminate GlobeNewswire
Avalyn Appoints Industry Veterans Jill Denning and Kimberley Cummings to Leadership
October 1, 2025

Avalyn Appoints Industry Veterans Jill Denning and Kimberley Cummings to Leadership

Indeterminate GlobeNewswire
CAMP4 Therapeutics Initiates GLP Toxicology Studies for CMP-SYNGAP-01
October 1, 2025

CAMP4 Therapeutics Initiates GLP Toxicology Studies for CMP-SYNGAP-01

Indeterminate GlobeNewswire
Starton Therapeutics to Participate in Panel at Longwood Healthcare Leaders Boston CEO, October 27-28, 2025
October 1, 2025

Starton Therapeutics to Participate in Panel at Longwood Healthcare Leaders Boston CEO, October 27-28, 2025

Indeterminate GlobeNewswire
ORYZON Strengthens Patent Portfolio for iadademstat with European Grant Decision Covering Combinations with PD1/PD-L1 Inhibitors
October 1, 2025

ORYZON Strengthens Patent Portfolio for iadademstat with European Grant Decision Covering Combinations with PD1/PD-L1 Inhibitors

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions